ADIPOQ and breast carcinoma: The reduction in the expression of AdipoR1 mRNA and the increase in the expression of AdipoR2 mRNA could indicate that the effective receptor for the in vivo signaling of adiponectin in breast cancer tissue is AdipoR1.